Related Experiment Video

Updated: May 3, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K

[MET signalling pathway and its therapeutic implications in gastrointestinal cancers]

Aziz Zaanan1, Pierre Laurent-Puig2, Julien Taieb3

  • 1Hôpital européen Georges-Pompidou, AP-HP, Service de gastroentérologie et oncologie digestive, 20, rue Leblanc, 75015 Paris, France, UMR-S775, Inserm, Paris, France.

Bulletin Du Cancer
|January 22, 2014
PubMed

Insights

The HGF-MET pathway is crucial in cancer development and progression. Targeting this system shows promise for digestive cancers, with MET expression potentially predicting treatment response.

Area of Science:

  • Oncology and Molecular Biology: Focuses on the MET receptor tyrosine kinase and its ligand HGF.
  • Cancer Signaling Pathways: Investigates the role of the HGF-MET system in cell proliferation, motility, invasion, and angiogenesis.

Context:

  • The HGF-MET signaling pathway is frequently dysregulated in various cancers.
  • This deregulation contributes to tumor development and progression.
  • Pharmacological inhibitors targeting HGF or MET are under investigation.

Purpose:

  • To review the role of the HGF-MET system in digestive cancers.
  • To evaluate the efficacy and safety of HGF-MET targeted therapies.
  • To explore MET tumor expression as a predictive biomarker.

Summary:

  • Targeted therapies inhibiting the HGF-MET pathway, including monoclonal antibodies and tyrosine kinase inhibitors, have shown promising results in digestive cancers.
  • Clinical studies indicate potential efficacy, but further confirmation via phase III trials is necessary.
  • MET tumor expression may serve as a predictive marker for treatment response in certain gastrointestinal tumors.

Impact:

  • Somatic alterations in the HGF-MET system represent viable therapeutic targets.
  • Identifying patients likely to respond to HGF-MET targeted treatments can be improved.
  • This research could lead to more personalized treatment strategies for digestive cancers.
Keywords:
HGFMETbiomarkergastrointestinal cancerstargeted therapy

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K